Top

Reactions Weekly

Published in:

01-07-2023 | Neutropenia | Case report

Gsk-2879552/tretinoin

Vomiting, febrile neutropenia and subdural haematoma: 4 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Roboz GJ, et al. Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes. Leukemia and Lymphoma 63 : 463-467, No. 2, Jan 2022. Available from: URL: https://doi.org/10.1080/10428194.2021.2012667

Title: Gsk-2879552/tretinoin
Vomiting, febrile neutropenia and subdural haematoma: 4 case reports
Publication date: 01-07-2023
Publisher: Springer International Publishing
Keywords: Neutropenia
Vomiting
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-43191-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Gsk-2879552/tretinoin

Vomiting, febrile neutropenia and subdural haematoma: 4 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Apixaban/atezolizumab/bevacizumab

Levodopa/carbidopa

Multiple drugs

Levofloxacin/norfloxacin

Pregabalin/tropicamide/unspecified opioid-receptor-agonists

FDA warns against use of Artri and Ortiga products